EATG, News ViiV Healthcare launches phase III programme to evaluate a long-acting, injectable HIV treatment regimen November 18, 2016 1060
Facebook Twitter Google+ Post Views: 1,060 ARTHIV/AIDSTreatment Share the News Facebook Twitter VKontakte Google+ Fast-track update on investments needed in the AIDS responce. UNAIDS 2016. Reference. European Antibiotic Awareness Day 2016 Related News 1393 Behavioral intervention reduces HIV transmission risk in young transgender women 1761 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis 1720 Vladimir Zhovtyak: European AIDS conference is a step forward to control the HIV/AIDS in Europe 1631 Patient Communities Agree on Shared Vision of HIV Treatment Regimen 2089 Glecaprevir/pibrentasvir is effective for people with HIV/HCV co-infection
1761 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis
ПОИСК ПО САЙТУ 
поиск по ресурсному центру 
